Cyclic hiv principal neutralizing determinant peptides

Details Cyclic hiv principal neutralizing determinant peptides Cyclic hiv principal neutralizing determinant peptides

C - Chemistry, Metallurgy

07

K

C07K 7/50 (2006.01) C07K 1/10 (2006.01) C07K 7/64 (2006.01) C07K 14/16 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2047033

46/GB6 PATENT 18149 TITLE OF THE INVENTION CYCLIC HIV PRINCIPAL NEUTRALIZING DETERMINANT PEPTIDES ABSTRACT OF THE DISCLOSURE Human Immunodeficiency Virus (EIV) Principal Neutralizing Determinant (PND) peptides, or peptides immunologically equivalent therewith, having the structure: Image 46/GB6 -i- 18149 wherein the ring system is formed by ring closure through a stable amide bond, are useful as analytical tools, as reagents in ELISA assays, or as reagents for making covalent conjugate immunogens. Conjugates containing these stable, cyclic peptides are useful for raising mammalian anti-peptide, anti-HIV, or HIV-neutralizing immune responses, and a composition containing such a conjugate may be used as a vaccine to prevent HIV-Disease, including Acquired Immune Deficiency Syndrome, (AIDS), or AIDS related complex, (ARC), or as an immunogen for treating humans afflicted with HIV-Diseases, such as AIDS or ARC.

Affiliated with

Also associated with

Rating

Cyclic hiv principal neutralizing determinant peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic hiv principal neutralizing determinant peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic hiv principal neutralizing determinant peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1516589